Welcome to the upgraded MacSphere! We're putting the finishing touches on it; if you notice anything amiss, email macsphere@mcmaster.ca

Lessons learned from COVID-19 for the post-antibiotic future

dc.contributor.authorWilson LA
dc.contributor.authorRogers Van Katwyk S
dc.contributor.authorFafard P
dc.contributor.authorViens AM
dc.contributor.authorHoffman SJ
dc.date.accessioned2021-04-05T15:48:39Z
dc.date.available2021-04-05T15:48:39Z
dc.date.issued2020-12
dc.date.updated2021-04-05T15:48:36Z
dc.description.abstract<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Introduction</jats:title> <jats:p>COVID-19 has rapidly and radically changed the face of human health and social interaction. As was the case with COVID-19, the world is similarly unprepared to respond to antimicrobial resistance (AMR) and the challenges it will produce. COVID-19 presents an opportunity to examine how the international community might better respond to the growing AMR threat.</jats:p> </jats:sec> <jats:sec> <jats:title>Main body</jats:title> <jats:p>The impacts of COVID-19 have manifested in health system, economic, social, and global political implications. Increasing AMR will also present challenges in these domains. As seen with COVID-19, increasing healthcare usage and resource scarcity may lead to ethical dilemmas about prioritization of care; unemployment and economic downturn may disproportionately impact people in industries reliant on human interaction (especially women); and international cooperation may be compromised as nations strive to minimize outbreaks within their own borders.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>AMR represents a slow-moving disaster that offers a unique opportunity to proactively develop interventions to mitigate its impact. The world’s attention is currently rightfully focused on responding to COVID-19, but there is a moral imperative to take stock of lessons learned and opportunities to prepare for the next global health emergency.</jats:p> </jats:sec>
dc.identifier.citationWilson, L.A., Rogers Van Katwyk, S., Fafard, P. et al. Lessons learned from COVID-19 for the post-antibiotic future. Global Health 16, 94 (2020). https://doi.org/10.1186/s12992-020-00623-xen_US
dc.identifier.doihttps://doi.org/10.1186/s12992-020-00623-x
dc.identifier.issn1744-8603
dc.identifier.issn1744-8603
dc.identifier.urihttp://hdl.handle.net/11375/26278
dc.publisherSpringer Science and Business Media LLC
dc.rights.licenseAttribution - CC BY
dc.rights.uri2
dc.subjectAntimicrobial resistance
dc.subjectCOVID-19
dc.subjectEmergency preparedness
dc.subjectInternational cooperation
dc.subjectAnti-Bacterial Agents
dc.subjectCOVID-19
dc.subjectCoronavirus Infections
dc.subjectDisaster Planning
dc.subjectDrug Resistance, Microbial
dc.subjectForecasting
dc.subjectGlobal Health
dc.subjectHumans
dc.subjectInternational Cooperation
dc.subjectPandemics
dc.subjectPneumonia, Viral
dc.titleLessons learned from COVID-19 for the post-antibiotic future
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Lessons learned from COVID-19 for the post-antibiotic future.pdf
Size:
450.99 KB
Format:
Adobe Portable Document Format
Description:
Published version